Article info

Download PDFPDF

Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis

Authors

  1. Correspondence to Dr Michal Segal Salto, ChemomAb Ltd, Tel Aviv 6158002, Israel; michal{at}chemomab.com
View Full Text

Citation

Mor A, Segal Salto M, Katav A, et al
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis

Publication history

  • Received January 27, 2019
  • Revised May 11, 2019
  • Accepted May 14, 2019
  • First published May 25, 2019.
Online issue publication 
August 12, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.